Piramal Pharma Limited
PPLPHARMANSE•Healthcare
Previous Close
₹135.72
Last Updated
20 Mar, 08:41 am
Market Cap
N/A
P/E Ratio
N/A
52W High
₹240.95
52W Low
₹134.60
Open
₹142.60
High
₹145.19
Low
₹139.08
Volume
26,91,026
Price Chart with Technical Indicators
• Blue line: Stock price
• Yellow dashed line: 20-day moving average
• Red dashed line: 50-day moving average
• Gray line: Trading volume (scaled for visualization)
Performance Analysis
52W Range Position
3.8%
Below midpoint
From 52W High
42.5%
From 52W Low
+3.0%
Average Price
₹141.78
Trading Metrics
Volume
26,91,026
Avg Volume
58,50,690.333
Volume Ratio
0.46x
Low activity
Volatility
2.03%
Moderate
Financial Fundamentals
Profit
₹0.00 Cr
Debt
₹0.00 Cr
Risk Assessment
Price Stability
Stable
Market Position
Weak
Liquidity
Moderate
Valuation Metrics
P/E Ratio
N/A
About Piramal Pharma Limited
Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Latest News
No news available for this stock.